In the BioHarmony Drug Report Database

"Preview" Icon

Lithium

Lithium Citrate, Lithonate (lithium) is a small molecule pharmaceutical. Lithium was first approved as Lithium Citrate on 1982-01-01. It is used to treat bipolar disorder, conduct disorder, depressive disorder, and post-traumatic stress disorders in the USA. The pharmaceutical is active against inositol monophosphatase 1. In addition, it is known to target glycogen synthase kinase-3 beta.

 

Trade Name

 

Lithium Citrate, Lithonate
 

Common Name

 

lithium
 

ChEMBL ID

 

CHEMBL2146126
 

Indication

 

bipolar disorder, conduct disorder, depressive disorder, post-traumatic stress disorders
 

Drug Class

 

Image (chem structure or protein)

Lithium structure rendering